Huaren Pharmaceutical Co Ltd (300110)

Currency in CNY
2.66
-0.04(-1.48%)
Closed·
300110 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.642.74
52 wk Range
2.413.75
Key Statistics
Bid/Ask
2.66 / 2.66
Prev. Close
2.7
Open
2.68
Day's Range
2.64-2.74
52 wk Range
2.41-3.75
Volume
23.75M
Average Volume (3m)
22.45M
1-Year Change
-27.9133%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300110 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Earnings

Latest Release
Apr 23, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
309.97M / --
EPS Revisions
Last 90 days

300110 Income Statement

Compare 300110 to Peers and Sector

Metrics to compare
300110
Peers
Sector
Relationship
P/E Ratio
−6.8x−4.4x−0.3x
PEG Ratio
−0.100.050.00
Price/Book
3.7x1.5x2.6x
Price / LTM Sales
2.4x3.8x2.9x
Upside (Analyst Target)
-51.4%56.7%
Fair Value Upside
Unlock6.0%10.2%Unlock

Huaren Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of medicines and medical equipment in China and internationally. It offers nephrology products, including peritoneal dialysate, hemofiltration replacement fluid, and hemofiltration basic solution; respiratory products, such as doxofylline, levofloxacin hydrochloride, and composite potassium hydrogen phosphate injections; caffeine citrate injection; and bulk preparations comprising sodium chloride, glucose, glucose and sodium chloride, compound sodium chloride, sodium lactate ringer's, and compound electrolyte injections, as well as sterile water for injection and rinsing liquid products. The company also provides therapeutic infusion, which includes blood volume expander, haemostatic, nervous system, circulatory system, anti-infectives, anti-hepatitis and hepatitis adjuvant drugs, antineoplastic and adjuvant drugs, and glucose metabolism; and rubber stoppers. In addition, it is involved in software development; investment management; and construction. The company was founded in 1998 and is based in Qingdao, China.

Employees
2549
Market
China

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
4.89M0.41%13.19M
Other Institutional Investors
390.83M33.06%1.06B
Public Companies & Retail Investors
786.50M66.53%2.12B
Total
1.18B100.00%3.19B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Xi'an Qujiang Culture Financial Holdings Co., Ltd.20.00%236,442,597638,395
Yongyu Hengfeng Investment Management Co., Ltd.4.86%57,496,123155,240

FAQ

What Is the Huaren Pharma (300110) Stock Price Today?

The Huaren Pharma stock price today is 2.66 CNY.

What Stock Exchange Does Huaren Pharma Trade On?

Huaren Pharma is listed and trades on the Shenzhen Stock Exchange.

What Is the Stock Symbol for Huaren Pharma?

The stock symbol for Huaren Pharma is "300110."

What Is the Huaren Pharma Market Cap?

As of today, Huaren Pharma market cap is 3.14B CNY.

What Is Huaren Pharma's Earnings Per Share (TTM)?

The Huaren Pharma EPS (TTM) is -0.39.

From a Technical Analysis Perspective, Is 300110 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Huaren Pharma Stock Split?

Huaren Pharma has split 4 times.

How Many Employees Does Huaren Pharma Have?

Huaren Pharma has 2549 employees.

What is the current trading status of Huaren Pharma (300110)?

As of Jul 30, 2026, Huaren Pharma (300110) is trading at a price of 2.66 CNY, with a previous close of 2.70 CNY. The stock has fluctuated within a day range of 2.64 CNY to 2.74 CNY, while its 52-week range spans from 2.41 CNY to 3.75 CNY.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.